Target intelligence / Profile preview

Guanylate cyclase 2G pseudogene (GUCY2GP)

Target
GUCY2GP
Molecular classification
Other (Pseudogene)
01

Overview

Guanylate cyclase 2G pseudogene (GUCY2GP) refers to a non-functional, inactivated human genomic sequence homologous to the active mouse gene Gucy2g, which encodes a receptor guanylyl cyclase enzyme. In mice, Gucy2g is involved in cyclic GMP synthesis and is predicted to play a role in guanylyl cyclase signaling[4]. In humans, this gene is disabled and does not produce a functional protein, thus it is classified as a unitary pseudogene[3]. There is no evidence supporting any biological function, disease association, or pharmacological relevance for the human GUCY2GP locus; it is not considered a therapeutic target.\n\nKey details:\n- **Pseudogene status** means the human gene is incapable of normal protein-coding function due to ancestral disabling mutations[3].\n- There is no established role in normal physiology or disease in humans.\n- No drugs target this molecule and it is not relevant for drug action, safety, or as a biomarker.\n\nNo authoritative databases list this pseudogene as a valid drug target, and it should not be confused with the homologous, functional guanylyl cyclases in other species[3][4].

Other names
GUCY2Gguanylate cyclase 2G homologpseudogeneGUCY2GP

Beyond the preview

Go deeper on Guanylate cyclase 2G pseudogene (GUCY2GP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanylate cyclase 2G pseudogene (GUCY2GP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call